Last reviewed · How we verify
Methycobal (MECOBALAMIN)
At a glance
| Generic name | MECOBALAMIN |
|---|---|
| Drug class | mecobalamin |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Prevention of Vitamin B12 Deficiency
Common side effects
Key clinical trials
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy (PHASE3)
- Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment (PHASE4)
- Electroacupuncture Regulation of Immune Cells in Herpes Zoster (NA)
- The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome (PHASE3)
- Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity (PHASE4)
- Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo (NA)
- Mecobalamin in Promoting Recurrent Laryngeal Nerve Function Recovery After Thyroid Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Methycobal CI brief — competitive landscape report
- Methycobal updates RSS · CI watch RSS